Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-02-12
2000-03-28
Killos, Paul J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562451, 562460, 562491, 564265, C07C 5976
Patent
active
060432799
ABSTRACT:
Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, and pyrrole derivatives. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
REFERENCES:
patent: 2897237 (1959-07-01), Carpenter et al.
patent: 3398121 (1968-08-01), Oxenrider et al.
patent: 3507906 (1970-04-01), Oxenrider et al.
patent: 3639464 (1972-02-01), Oxenrider et al.
patent: 4141995 (1979-02-01), Saunders et al.
patent: 4539154 (1985-09-01), Krebs
patent: 4548723 (1985-10-01), Shippey
patent: 4833240 (1989-05-01), Maignan et al.
patent: 4877805 (1989-10-01), Kligman
patent: 4898864 (1990-02-01), Maignan et al.
patent: 4981784 (1991-01-01), Evans et al.
patent: 5023341 (1991-06-01), Chandraratna
patent: 5023363 (1991-06-01), Maignan et al.
patent: 5053523 (1991-10-01), Chandraratna
patent: 5071773 (1991-12-01), Evans et al.
patent: 5093516 (1992-03-01), Maignan et al.
patent: 5399586 (1995-03-01), Davies et al.
patent: 5466861 (1995-11-01), Dawson et al.
Angel et al., Mol. Cell. Biol., 7:2256 (1987).
Ashwell et al., Proc. Natl'l Acad. Sci., 90:6170-74 (1993).
Berger, T.S. et al., J. Steroid Biochem. Molec. Biol., 41:733-38 (1992).
Bradley, L.M., Selected Methods in Cellular Immunology, Ch. 10.1, pp. 235-38, Mishell & Shiigi (eds.), Freeman & Co., New York (1980).
Brietman et al., Proc. Nat'l Acad. Sci., 77:2936 (1980).
Brand, N. et al., Nature, 332:850-53 (Apr. 28, 1988).
Chemical Abstracts, vol. 84, No. 15, Abstract No. 105844 (Apr. 12, 1976).
Chemical Abstracts, vol. 88, No. 20, Abstract No. 144612 (May 15, 1978).
Englert, Gerhard, Helvetica Chimica Acta, vol. 58, Fasc. 8, pp. 2367-2390 (1975).
Evans, R.M., Science, 240:889-95 (May 13, 1988).
Giguere, V. et al., Nature, 330:624-29 (Dec. 17, 1987).
Gordon et al., New England J. Med., 321:1311 (1989).
Heyman, R.A. et al., Cell, 68:397-406 (Jan. 24, 1992).
Hollenberg, S.M. et al., Cell, 55:899-906. (Dec. 2, 1988).
Ishikawa, T. et al., Mol. Endo., 4:837-44 (1990).
Isseman & Green, Nature, 347:645-49 (1990).
Jong, L. et al., J. Med. Chem., 36:2605-13 (1993).
Kliewer et al., Nature, 358:771 (1992).
Kligman, L.H. et al., J. of Invest. Derm., 73:354-58 (1979).
Ladias et al., Science, 251:561-65 (1991).
Lafyatis et al., Mol. Endocrinol., 4:973 (1990).
Lehmann, J.M. et al., Science, 258:1944-46 (1992).
Levin, A.A. et al., Nature, 355:359-61 (Jan. 23, 1992).
Loeliger, P. et al., Eur. J. Med. Chem. -- Chimica Therapeutica, vol. 15, No. 1, pp. 9-15 (1980).
Mangelsdorf, D.J. et al., Nature, 345:224-29 (May 17, 1990).
Mangelsdorf, D.J. et al., Cell, 66:555-61 (Aug. 9, 1991).
Mangelsdorf, D.J. et al., Genes & Devel., 6:329-44 (1992).
Mezick, J.A. et al., J. of Inves. Derm., 83:110-13 (1984).
Miyajima et al., Nucleic Acids Research, 16:11057-74 (1988).
Mlodzik et al., Cell, 60:211-24 (1990).
Murtaugh et al., J. Biol. Chem., 258:11074 (1983).
Oro et al., Nature, 347:298-301 (1990).
Petkovich, M. et al., Nature, 330:444-50 (Dec. 3, 1987).
Rottman et al., Mol. Cell. Biol., 11:3814-20 (1991).
Rubin et al., Nature, 353:265 (1991).
Schenk, H. et al., Acta Cryst., vol. B34, pp. 505-507 (1978).
Shirvastav et al., Cancer Res., 40:4438 (1980).
Sladek et al., Genes & Development, 4:2353-65 (1990).
Umesono, K. et al., Nature, 336:262-65 (Nov. 17, 1988).
Umesomo, K. & Evans, R.M., Cell, 57:1139-46 (Jun. 30, 1989).
Wang et al., Nature, 340:163-66 (1989).
Wecksler & Norman, Anal. Biochem., 92:314-23 (1979).
Widom et al., Mol. Cell. Biol., 12:3380-89 (1992).
Yang, N. et al., Proc. Natl. Acad. Sci. USA, 88:3559-63 (May 1991).
Yoshihide, et al., Chemical Abstracts, 4473Of, vol. 83, p. 72 (1975).
Yuspa, S.H. et al., Cancer Research, 43:5707-12 (Dec., 1983).
Boehm Marcus F.
Heyman Richard A.
Killos Paul J.
Ligand Pharmaceuticals Incorporated
LandOfFree
Compounds having selective activity for retinoid X receptors, an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds having selective activity for retinoid X receptors, an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds having selective activity for retinoid X receptors, an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1326453